Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wittmannon Apr 05, 2019 11:41am
206 Views
Post# 29587820

RE:What is another 17¢

RE:What is another 17¢PLI won't go belly up.Theres value there.But common shareholders will get hit.I find it amazing that some here have tried to spin a potentialpositive about this debt to equity nonsense.What equity are these people posting about??.The only equity they have are the facilities that are producing plasma...That's it.And they've done that for years.Assigning equity value on what else exactly?Impending FDA approval?..successful trials?..idiotic hopes for the voucher?
No ..it doesn't work that way with a company this much in debt.
Now ,with a restructured company ,the shares owned by institutions will be converted to benefit them for the future.It won't matter to them if they lose money on a consolidation.They've all got tools for investing that retailers don't have...namely cash and tax offset strategies.
Retailors  holding common shares actually aren't in that position.We can only offset gains with losses and besides ,we all lack inside info that you can bet institutions have.Besides that how much money does the average Joe here have to invest back into a new PLI?
It's going to be interesting to see which direction they go.They've only got one segment of their operations that's profitable..it's that segment that I'm interested in .I wonder how that's going to play out.
Bullboard Posts